TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34348723

Group type: EXPERIMENTAL
Intervention: Arm A - Package of interventions aimed at health service delivery optimization
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Arm B - Strengthening community platforms in addition to Arm A
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 39
Study: 35600575

Group type: COMPARATOR
Intervention: Dapagliflozin
Number of subjects: 68

Group type: COMPARATOR
Intervention: Exenatide
Number of subjects: 68

Group type: COMPARATOR
Intervention: Dapagliflozin plus Exenatide
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 68
Study: 34969771

Group type: EXPERIMENTAL
Intervention: 30 mg BMS-986278
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: 60 mg BMS-986278
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study: 33845761

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.6 µg/kg/h)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 139
Study: 32893313

Group type: EXPERIMENTAL
Intervention: NAVA (Neurally Adjusted Ventilatory Assist)
Number of subjects: 306

Group type: COMPARATOR
Intervention: Conventional lung-protective mechanical ventilation (MV)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 306

Group type: COMPARATOR
Intervention: Control
Number of subjects: 306
Study: 34981180

Group type: EXPERIMENTAL
Intervention: Topiramate (200 mg/day for 5 weeks)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 32007328

Group type: EXPERIMENTAL
Intervention: Calling
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Job satisfaction
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Administration, workload, relationships with colleagues, work itself, remuneration and benefits
Number of subjects: 547
Study: 33829803

Group type: EXPERIMENTAL
Intervention: FORNET (Narrative Exposure Therapy for Forensic Offender Rehabilitation)
Number of subjects: 0
Study: 33158948

Group type: EXPERIMENTAL
Intervention: Low-volume high-intensity interval exercise (LV-HIIE)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Continuous moderate-intensity aerobic exercise (CME)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sedentary control (CON)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Insulin resistance index (IRI)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Lipids
Number of subjects: 23
Study: 32371448

Group type: EXPERIMENTAL
Intervention: Direct electrical stimulation (DES)
Number of subjects: 75
Study: 34730461

Group type: EXPERIMENTAL
Intervention: Dried egg white protein supplementation (20 g protein daily)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Isocaloric maltodextrin supplement
Number of subjects: 29
Study: 34723741

Group type: EXPERIMENTAL
Intervention: Brief preexamination mindfulness intervention
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 49
Study: 33131393

Group type: EXPERIMENTAL
Intervention: Nonsurgical care for subacromial pain syndrome
Number of subjects: 98
Study: 35240010

Group type: EXPERIMENTAL
Intervention: CT group
Number of subjects: 3561

Group type: COMPARATOR
Intervention: ICA group
Number of subjects: 3561
Study: 32166337

Group type: EXPERIMENTAL
Intervention: Radiomics signature
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Clinical signature
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Combined signature
Number of subjects: 145
Study: 33407805

Group type: EXPERIMENTAL
Intervention: Expert-led e-cigarette prevention program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elected peer-leader led e-cigarette prevention program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random peer-leader led e-cigarette prevention program
Number of subjects: 0
Study: 32102946

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 2333

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2333
Study: 35356054

Group type: EXPERIMENTAL
Intervention: 30-minutes of daily morning bright white light (BWL)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Dim red light (DRL)
Number of subjects: 39
Study: 35353757

Group type: EXPERIMENTAL
Intervention: Cardiovascular disease (congestive heart failure or hypertension)
Number of subjects: 47
Study: 32556699

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (NMB) with standard intraabdominal pressure (IAP) 20 mmHg
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (NMB) with low intraabdominal pressure (IAP) 12 mmHg
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Moderate neuromuscular blockade (NMB) with low intraabdominal pressure (IAP) 12 mmHg
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Moderate neuromuscular blockade (NMB) with standard intraabdominal pressure (IAP) 20 mmHg
Number of subjects: 62
Study: 32854375

Group type: EXPERIMENTAL
Intervention: Optimal drink
Number of subjects: 55

Group type: COMPARATOR
Intervention: Least optimal drink
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 55
Study: 34713539

Group type: EXPERIMENTAL
Intervention: Subantibiotic dose oral doxycycline 40 mg modified-release capsules once daily (SDD40)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 235
Study: 34970565

Group type: EXPERIMENTAL
Intervention: Computer-Assisted System (CAD)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (no CAD)
Number of subjects: 6
Study: 33885773

Group type: EXPERIMENTAL
Intervention: Default dispense quantity of 10 tablets
Number of subjects: 21331

Group type: COMPARATOR
Intervention: No change in EHR
Number of subjects: 21331
Study: 34325109

Group type: EXPERIMENTAL
Intervention: Doxorubicin 60 mg/m2 followed by trabectedin 1.1 mg/m2 as a 3‐h infusion on day 1 and pegfilgrastim on day 2, every 3 weeks, up to six cycles
Number of subjects: 108
Study: 32428430

Group type: EXPERIMENTAL
Intervention: Decision Aid (DA) implementation
Number of subjects: 248
Study: 34358298

Group type: EXPERIMENTAL
Intervention: N-terminal pro-B-type natriuretic peptide (NT-proBNP)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Cardiac troponin T (cTnT-hs)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Interleukin-6 (IL-6)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Growth differentiation factor-15 (GDF-15)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Fibroblast growth factor 23 (FGF-23)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Urokinase receptor (uPAR)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Trefoil factor 3 (TFF3)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Tumour necrosis factor receptor 1 (TNFR1)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: TNF-related apoptosis-inducing ligand receptor 2 (TRAILR2)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Cathepsin L1 (CTSL1)
Number of subjects: 517
Study: 32956959

Group type: EXPERIMENTAL
Intervention: Resilience and interpersonal relationships
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Resilience
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Interpersonal relationships
Number of subjects: 450
Study: 32612088

Group type: EXPERIMENTAL
Intervention: OPLFE
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Mixed plant extract with OPLFE
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 34674896

Group type: EXPERIMENTAL
Intervention: Active laser therapy (Ga-As super pulsed laser therapy)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo laser therapy (inactive laser)
Number of subjects: 36
Study: 34064427

Group type: EXPERIMENTAL
Intervention: Fascia Iliaca Compartment Block (FICB) with 0.375% ropivacaine, nonopioid analgesics (paracetamol, metamizole, pregabalin), and oxycodone as rescue analgesia
Number of subjects: 109

Group type: COMPARATOR
Intervention: Standard intravenous analgesia with FICB
Number of subjects: 109
Study: 35884677

Group type: COMPARATOR
Intervention: Neuromuscular electrical stimulation (NMES)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Electromyography bridge (EMGB)
Number of subjects: 24
Study: 34393206

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005%
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Timolol 0.25%
Number of subjects: 14

Group type: COMPARATOR
Intervention: No medications
Number of subjects: 14
Study: 36272295

Group type: EXPERIMENTAL
Intervention: Ofloxacin ear drops
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Vaseline gauze (VG)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Dry gelfoam alone
Number of subjects: 70
Study: 33560754

Group type: EXPERIMENTAL
Intervention: Bone-loading exercises (weight-bearing and resistance training) for 12 months
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Self-efficacy strategies
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Barriers to exercise
Number of subjects: 72
Study: 36619342

Group type: EXPERIMENTAL
Intervention: Big patch (30,000 IU cholecalciferol)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Small patch (30,000 IU cholecalciferol)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both patches (30,000 IU cholecalciferol)
Number of subjects: 30
Study: 36409638

Group type: EXPERIMENTAL
Intervention: Spontaneous void (SV)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Retrograde fill (RF)
Number of subjects: 109
Study: 32621248

Group type: EXPERIMENTAL
Intervention: Intervention targeting physiotherapists
Number of subjects: 174

Group type: COMPARATOR
Intervention: Intervention targeting surgeons
Number of subjects: 174
Study: 32680778

Group type: EXPERIMENTAL
Intervention: Stem cell transplantation using bone marrow-derived mesenchymal stem cells
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Single-stage procedure with accelerated rehabilitation
Number of subjects: 3
Study: 32424502

Group type: EXPERIMENTAL
Intervention: Perceived social support
Number of subjects: 326
Study: 35049477

Group type: EXPERIMENTAL
Intervention: Groups 4 Health (G4H)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 174
Study: 33285673

Group type: EXPERIMENTAL
Intervention: Thread embedding acupuncture (TEA) combined with acupuncture (AT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Acupuncture (AT)
Number of subjects: 38
Study: 36272766

Group type: EXPERIMENTAL
Intervention: Montage bone putty and wire cerclage
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wire cerclage alone
Number of subjects: 60
Study: 34635374

Group type: EXPERIMENTAL
Intervention: Biological contamination
Number of subjects: 642

Group type: EXPERIMENTAL
Intervention: Chemical contamination
Number of subjects: 642

Group type: EXPERIMENTAL
Intervention: Pure environments
Number of subjects: 642

Group type: EXPERIMENTAL
Intervention: Hazard signs/icons
Number of subjects: 642

Group type: COMPARATOR
Intervention: Neutral scenes
Number of subjects: 642

Group type: COMPARATOR
Intervention: Neutral icons
Number of subjects: 642
Study: 32043347

Group type: EXPERIMENTAL
Intervention: HIIEFAST
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: HIIEHPFED
Number of subjects: 2
Study: 35174663

Group type: EXPERIMENTAL
Intervention: Perindopril 4 mg
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo (no perindopril)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Leucine 2.5 g thrice daily
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo (no leucine)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Meta-analysis of ACE inhibitors/ARBs
Number of subjects: 145
Study: 34544253

Group type: EXPERIMENTAL
Intervention: PlayStation® video games (active distraction)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Cartoon film (passive distraction)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both groups (active and passive distraction)
Number of subjects: 34
Study: 32617000

Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation with posturography for 10 sessions
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation with posturography for 5 sessions
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups (10 sessions and 5 sessions)
Number of subjects: 40
Study: 34216878

Group type: EXPERIMENTAL
Intervention: Li Maneuver
Number of subjects: 254

Group type: COMPARATOR
Intervention: Gufoni Maneuver
Number of subjects: 254
Study: 32594675

Group type: EXPERIMENTAL
Intervention: Triple chronotherapy (combined total sleep deprivation, light therapy, and sleep phase advance) add-on to standard pharmacological treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard pharmacological treatment
Number of subjects: 0
Study: 35474627

Group type: EXPERIMENTAL
Intervention: Family-based treatment (FBT)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Inpatient multimodal treatment (IMT)
Number of subjects: 7
Study: 33865471

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 8719

Group type: COMPARATOR
Intervention: 3-monthly ART dispensing
Number of subjects: 8719

Group type: EXPERIMENTAL
Intervention: 6-monthly ART dispensing
Number of subjects: 8719
Study: 33665919

Group type: EXPERIMENTAL
Intervention: Resilience-based intervention
Number of subjects: 23
Study: 34334898

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 400 mg twice on day 1, then 400 mg once daily from day 2 to day 5
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 110
Study: 35144787

Group type: EXPERIMENTAL
Intervention: Balloon-Expandable Stent (BES)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Self-Expandable Stent (SES)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Both BES and SES
Number of subjects: 92
Study: 34372928

Group type: EXPERIMENTAL
Intervention: Nutricia™ preOp® (400 mL) administered to the pre-op group after 10 hours of fasting.
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (no carbohydrate-enriched drink).
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Both groups (pre-op and control) after 10 hours of fasting.
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Both groups (pre-op and control) after fasting.
Number of subjects: 81
Study: 34936159

Group type: COMPARATOR
Intervention: Traditional lecture classroom (TC)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Mobile application (APP)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Combination of both methods (TC-APP)
Number of subjects: 36
Study: 34069907

Group type: EXPERIMENTAL
Intervention: Stroboscopic vision training
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Balance training
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control (no training)
Number of subjects: 73
Study: 32618267

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DHAp) administered during MDA/fMDA
Number of subjects: 336821
Study: 35278154

Group type: EXPERIMENTAL
Intervention: Adaptive cognitive training
Number of subjects: 62

Group type: COMPARATOR
Intervention: Educational training control
Number of subjects: 62
Study: 33909185

Group type: COMPARATOR
Intervention: tofacitinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: upadacitinib
Number of subjects: 0
Study: 35120577

Group type: EXPERIMENTAL
Intervention: High single dose of vitamin D (140,000 IU) followed by treatment as usual (TAU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo + treatment as usual (TAU)
Number of subjects: 0
Study: 33828219

Group type: COMPARATOR
Intervention: Exploratory cohort patients measuring upper vertical lung length (uVLL), lower vertical lung length (lVLL), total vertical lung length (tVLL), and l/uVLL ratio on chest X-rays.
Number of subjects: 280

Group type: COMPARATOR
Intervention: lVLL measurement
Number of subjects: 280

Group type: COMPARATOR
Intervention: tVLL measurement
Number of subjects: 280

Group type: COMPARATOR
Intervention: l/uVLL ratio measurement
Number of subjects: 280
Study: 33899607

Group type: EXPERIMENTAL
Intervention: Generalized linear models (GLMs) without adjusting for covariates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjustment method proposed based on asymptotic results
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Commonly used generalized linear models (e.g., logistic regression, Poisson regression)
Number of subjects: 0
Study: 34166402

Group type: EXPERIMENTAL
Intervention: Current asthma in 2016 (11.5%) compared to 2008 (9.3%)
Number of subjects: 2484

Group type: EXPERIMENTAL
Intervention: Growing up on a farm
Number of subjects: 2484

Group type: EXPERIMENTAL
Intervention: Current allergic rhinitis (AR)
Number of subjects: 2484

Group type: EXPERIMENTAL
Intervention: Current smoking in 2016 (15.2%) compared to 2008 (20.3%)
Number of subjects: 2484

Group type: EXPERIMENTAL
Intervention: Use of electronic cigarettes in 2016 (4.8%)
Number of subjects: 2484
Study: 34909972

Group type: EXPERIMENTAL
Intervention: Oral dydrogesterone 40 mg/day
Number of subjects: 73

Group type: COMPARATOR
Intervention: Micronized vaginal progesterone 800 mg/day
Number of subjects: 73
Study: 33987239

Group type: EXPERIMENTAL
Intervention: EGHB010
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 33399242

Group type: EXPERIMENTAL
Intervention: Endocrine therapy without chemotherapy
Number of subjects: 0
Study: 33234974

Group type: EXPERIMENTAL
Intervention: Semiautomatic stapler
Number of subjects: 649

Group type: COMPARATOR
Intervention: Needle arm (conventional thread)
Number of subjects: 649
Study: 35475947

Group type: EXPERIMENTAL
Intervention: Personalized skill sequences (standard, strengths-prioritized, deficits-prioritized)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 6 sessions of treatment
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 12 sessions of treatment
Number of subjects: 70
Study: 34743682

Group type: EXPERIMENTAL
Intervention: Regular moderate intensity exercise during pregnancy
Number of subjects: 855

Group type: COMPARATOR
Intervention: Standard antenatal care
Number of subjects: 855
Study: 36461040

Group type: EXPERIMENTAL
Intervention: Virtual Reality session (10 minutes using a head-mounted VR device to watch and listen to a nature scene)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 150
Study: 33426575

Group type: EXPERIMENTAL
Intervention: Menthol mouth-rinse (MENT)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Hot water immersion (HOT)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Water mouth-rinse (CON)
Number of subjects: 8
Study: 35439637

Group type: EXPERIMENTAL
Intervention: Sleep First group (encoded word pairs at night before sleep)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Wake First group (encoded word pairs in the morning before a day of wakefulness)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 56
Study: 33684772

Group type: EXPERIMENTAL
Intervention: Witnessing overdose
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Experiencing overdose
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Access to naloxone
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Carrying naloxone
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Regularly injecting alone
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Others having naloxone when injecting
Number of subjects: 502
Study: 35436174

Group type: EXPERIMENTAL
Intervention: Online hearing support
Number of subjects: 136

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 136
Study: 34511091

Group type: EXPERIMENTAL
Intervention: Intra-articular polynucleotides and hyaluronic acid (PNHA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA)
Number of subjects: 100
Study: 32412157

Group type: EXPERIMENTAL
Intervention: Nivolumab treatment <2 years
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Nivolumab treatment for 2 years
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Nivolumab treatment >2 years
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Nivolumab treatment (all groups)
Number of subjects: 259
Study: 36335797

Group type: EXPERIMENTAL
Intervention: Virtual Reality Learning Environment (VRLE)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Traditional 2-dimensional images (Control)
Number of subjects: 69
Study: 33974972

Group type: EXPERIMENTAL
Intervention: Hepatic hilar and celiac plexus nerve blocks
Number of subjects: 92

Group type: COMPARATOR
Intervention: Standard intraprocedural local anesthetic, intra‐arterial lidocaine, and intravenous analgesia (Control)
Number of subjects: 92
Study: 32522320

Group type: EXPERIMENTAL
Intervention: Hall technique (HT)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Stainless steel crown (SSC)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Modified atraumatic restorative treatment (mART)
Number of subjects: 123
Study: 35987550

Group type: EXPERIMENTAL
Intervention: Compound intervention (IP + WBE), n=87
Number of subjects: 251

Group type: COMPARATOR
Intervention: Information provision arm (IP), n=84
Number of subjects: 251

Group type: COMPARATOR
Intervention: Psychological well-being enhancement arm (WBE), n=80
Number of subjects: 251
Study: 33386031

Group type: EXPERIMENTAL
Intervention: Focal muscular vibration (FMV) applied to flexor muscles of the upper limb (Group A)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Focal muscular vibration (FMV) applied to extensor muscles of the upper limb (Group B)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 28
Study: 34544843

Group type: EXPERIMENTAL
Intervention: Confocal laser endomicroscopy (CLE) after wheat exposure
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Confocal laser endomicroscopy (CLE) at 6 months follow-up
Number of subjects: 147
Study: 33212540

Group type: EXPERIMENTAL
Intervention: Low-Dose Computed Tomography (LDCT) screening
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LDCT screening until the age of 80
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stopping LDCT screening at age 75
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risk prediction models based on smoking history, sex, and age
Number of subjects: 0
Study: 32931375

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 11